Prescription patterns of ambrisentan in some cities of Colombia.

Luis Fernando Valladales-RestrepoAndrés Gaviria-MendozaManuel Enrique Machado-DuqueÁlvaro Vallejos-NarváezJorge Enrique Machado-Alba

Published in: The clinical respiratory journal (2024)

Adherence to ambrisentan was good, but its persistence at 1 year was low. The dosages of the drug used were in accordance with the recommendations of the clinical practice guidelines, and it was used in combination therapy, especially with phosphodiesterase 5 inhibitors.

Keyphrases

combination therapy
clinical practice
adverse drug
type diabetes
drug induced
metabolic syndrome
adipose tissue
insulin resistance
weight loss